𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics

✍ Scribed by Cox, Jürgen; Matic, Ivan; Hilger, Maximiliane; Nagaraj, Nagarjuna; Selbach, Matthias; Olsen, Jesper V; Mann, Matthias


Book ID
109946747
Publisher
Nature Publishing Group
Year
2009
Tongue
English
Weight
467 KB
Volume
4
Category
Article
ISSN
1750-2799

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Utility of a physiologically–based pharm
✍ Joseph A. Grillo; Ping Zhao; Julie Bullock; Brian P. Booth; Min Lu; Kathy Robie- 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

Background: Rivaroxaban is an oral Factor Xa inhibitor. The primary objective of this communication was to quantitatively predict changes in rivaroxaban exposure when individuals with varying degrees of renal impairment are co-administered with another drug that is both a P-gp and a moderate CYP3A4